KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer

Autor: Giovanni Scambia, Gabriele Babini, Simona Mozzetti, Daniela Gallo, Maria Cristina De Rosa, Marianna Buttarelli, Alessandra Ciucci, Marta De Donato, Gloria Arduini

Publikováno v: Journal of experimental & clinical cancer research (Online) 39 (2020): 265. doi:10.1186/s13046-020-01775-9
info:cnr-pdr/source/autori:Marta De Donato 1 2, Gabriele Babini 3, Simona Mozzetti 2, Marianna Buttarelli 1 2, Alessandra Ciucci 1 2, Gloria Arduini 4, Maria Cristina De Rosa 5, Giovanni Scambia 2 3, Daniela Gallo 6 7/titolo:KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer/doi:10.1186%2Fs13046-020-01775-9/rivista:Journal of experimental & clinical cancer research (Online)/anno:2020/pagina_da:265/pagina_a:/intervallo_pagine:265/volume:39
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-17 (2020)
Journal of Experimental & Clinical Cancer Research : CR

Background In spite of great progress in the surgical and clinical management, until now no significant improvement in overall survival of High-Grade Serous Ovarian Cancer (HGSOC) patients has been achieved. Important aspects for disease control rema

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8ece3d1e08b2b4e9f227f7a64ec035
https://pubmed.ncbi.nlm.nih.gov/33250051/